ELI LILLY PAKISTAN PVT LTD

ELI LILLY PAKISTAN PVT LTD is primarily a pharmaceutical manufacturer and distributor. As a subsidiary of the global pharmaceutical company Eli Lilly and Company, it is involved in the local production (which can include formulation, packaging, and sometimes full manufacturing) and the comprehensive marketing and distribution of its pharmaceutical products within Pakistan. Therefore, it functions as both a manufacturer (factory) and a trader/distributor of its own specialized products.

Company Introduction:

Eli Lilly Pakistan Private Limited is the Pakistani subsidiary of Eli Lilly and Company, a leading global pharmaceutical corporation headquartered in the United States. Established to serve the healthcare needs of the Pakistani population, the company plays a crucial role in bringing innovative medicines to the local market.

Eli Lilly Pakistan is dedicated to the research, development, manufacturing, and distribution of a wide range of pharmaceutical products. Its portfolio typically includes treatments for significant health challenges such as diabetes, oncology (cancer), immunology, neuroscience, and other critical therapeutic areas. The company is committed to improving patient outcomes by providing high-quality, effective medications and contributing to the advancement of healthcare in Pakistan.

Operating with a focus on ethical practices and scientific excellence, Eli Lilly Pakistan aims to uphold the global standards of its parent company while addressing the specific health requirements and regulatory landscape of the Pakistani market. It collaborates with healthcare professionals, government bodies, and patient organizations to ensure access to its life-changing therapies.

ELI LILLY PAKISTAN PVT LTD manufactures or markets products primarily in the following therapeutic areas:

Diabetes

Humalog (insulin lispro)

Humulin (insulin human)

Trulicity (dulaglutide)

Jardiance (empagliflozin) - co-marketed with Boehringer Ingelheim

Oncology

Alimta (pemetrexed)

Cyramza (ramucirumab)

Verzenio (abemaciclib)

Immunology

Taltz (ixekizumab)

Olumiant (baricitinib)

Emgality (galcanezumab)

Neuroscience

Zyprexa (olanzapine)

Cymbalta (duloxetine)

Men's Health

Cialis (tadalafil)